10X Genomics CEO Sees a Lot of Growth Potential in Asia

The transcript discusses 10X's mission to advance biological understanding through innovative tools and applications. It highlights the company's revenue growth, product expansion, and strategic investments in R&D and global markets. The conversation covers funding, future growth opportunities, and the importance of spatial analysis in biology. The company aims to build a significant business without focusing on exit strategies, while also exploring potential IPOs. The transcript concludes with insights from the JP Morgan Healthcare Conference and plans for further expansion.

What is the main belief regarding the current century in terms of biology?

What are the key obstacles mentioned in understanding biology?

How does the company plan to improve the understanding of biology?

What were the significant achievements of the company in the past year?

What future growth opportunities does the company see with the new funding?

What are the new areas of investment mentioned for the company?

What is the company's perspective on exit strategies?